Catherine Langham, Director at Eiger Biopharmaceuticals, holds 0.00 shares in Eiger Biopharmaceuticals (Ticker: EIGRQ), holds 92.57K shares in Celadon Group (Ticker: CGIP), holds 0.00 shares in The Finish Line (Ticker: FINL). Most recently, Catherine Langham ― shares of Eiger Biopharmaceuticals on ― for an estimated value of ―.
Catherine Langham latest transaction was an Uninformative Buy of ―.
What was Catherine Langham's most profitable transaction?
Catherine Langham’s most profitable transaction was an Informative Sell of FINL stock on May 1, 2014. The return on the trade was 9.80%.
What is Catherine Langham's role in Eiger Biopharmaceuticals?
Catherine Langham's role in Eiger Biopharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.